SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-001231
Filing Date
2019-04-30
Accepted
2019-04-29 19:04:57
Documents
57
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gala_10q-022819.htm 10-Q 316228
2 CERTIFICATION gala_10q-ex3101.htm EX-31.1 10091
3 CERTIFICATION gala_10q-ex3201.htm EX-32.1 4409
  Complete submission text file 0001683168-19-001231.txt   2230523

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE glag-20190228.xml EX-101.INS 360586
5 XBRL SCHEMA FILE glag-20190228.xsd EX-101.SCH 29690
6 XBRL CALCULATION FILE glag-20190228_cal.xml EX-101.CAL 48062
7 XBRL DEFINITION FILE glag-20190228_def.xml EX-101.DEF 83425
8 XBRL LABEL FILE glag-20190228_lab.xml EX-101.LAB 207599
9 XBRL PRESENTATION FILE glag-20190228_pre.xml EX-101.PRE 170310
Mailing Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612
Business Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612 949-851-9261
Gala Pharmaceutical Inc. (Filer) CIK: 0001513403 (see all company filings)

IRS No.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55998 | Film No.: 19777778
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl